Published October 2018
| Version v1
Journal article
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Creators
- 1. Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario (Canada)
- 2. NRGOncologyStatistics and Data Management Center, Philadelphia (United States)
- 3. Emory University, Winship Cancer Institute, Atlanta (United States)
- 4. Centre Hospitalier de l'Université de Montréal, Montreal, Quebec (Canada)
- 5. Froedtert and the Medical College of Wisconsin, Milwaukee (United States)
Description
There is considerable interest in very short (ultrahypofractionated) radiation therapy regimens to treat prostate cancer based on potential radiobiological advantages, patient convenience, and resource allocation benefits. Our objective is to demonstrate that detectable changes in health-related quality of life measured by the bowel and urinary domains of the Expanded Prostate Cancer Index Composite (EPIC-50) were not substantially worse than baseline scores.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2018.06.008Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2018.06.008;
- PII
- S0360301618309611;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 102
- Journal Issue
- 2
- Journal Page Range
- p. 287-295
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53017280
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- NEOPLASMS; PATIENTS; PROSTATE; QUALITY OF LIFE; RADIOTHERAPY
- Descriptors DEC
- BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.